Page last updated: 2024-08-18

2,5-hexanedione and Ambulation Disorders, Neurologic

2,5-hexanedione has been researched along with Ambulation Disorders, Neurologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hou, LY; Wang, QS; Xie, KQ; Yu, SF; Zhang, CL; Zhao, XL	1

Other Studies

1 other study(ies) available for 2,5-hexanedione and Ambulation Disorders, Neurologic

Article	Year
2,5-hexanedione (HD) treatment alters calmodulin, Ca2+/calmodulin-dependent protein kinase II, and protein kinase C in rats' nerve tissues. Toxicology and applied pharmacology, 2008, Oct-01, Volume: 232, Issue:1 Topics: Animals; Body Weight; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calmodulin; Cell Membrane; Cerebral Cortex; Cytosol; Gait; Gait Disorders, Neurologic; Hexanones; Lameness, Animal; Male; Nervous System; Neurofilament Proteins; Neurotoxicity Syndromes; Phosphorylation; Protein Kinase C; Rats; Rats, Wistar; Sciatic Nerve; Spinal Cord; Time Factors; Up-Regulation	2008

Article

Year

2,5-hexanedione (HD) treatment alters calmodulin, Ca2+/calmodulin-dependent protein kinase II, and protein kinase C in rats' nerve tissues.

Toxicology and applied pharmacology, 2008, Oct-01, Volume: 232, Issue:1

Topics: Animals; Body Weight; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calmodulin; Cell Membrane; Cerebral Cortex; Cytosol; Gait; Gait Disorders, Neurologic; Hexanones; Lameness, Animal; Male; Nervous System; Neurofilament Proteins; Neurotoxicity Syndromes; Phosphorylation; Protein Kinase C; Rats; Rats, Wistar; Sciatic Nerve; Spinal Cord; Time Factors; Up-Regulation

2008